• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful repositioning of the subcutaneous implantable cardioverter-defibrillator lead to avoid inappropriate shock.

作者信息

Fukunaga Hiroshi, Inoue Kanki, Sekiguchi Yukio, Nitta Junichi, Isobe Mitsuaki

机构信息

Department of Cardiology Sakakibara Heart Institute Tokyo Japan.

出版信息

J Arrhythm. 2023 Jan 4;39(1):74-77. doi: 10.1002/joa3.12805. eCollection 2023 Feb.

DOI:10.1002/joa3.12805
PMID:36733326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9885306/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/9885306/c77b5ed5bfb2/JOA3-39-74-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/9885306/3efa7969bb18/JOA3-39-74-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/9885306/b458ccff763b/JOA3-39-74-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/9885306/c77b5ed5bfb2/JOA3-39-74-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/9885306/3efa7969bb18/JOA3-39-74-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/9885306/b458ccff763b/JOA3-39-74-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/9885306/c77b5ed5bfb2/JOA3-39-74-g001.jpg

相似文献

1
Successful repositioning of the subcutaneous implantable cardioverter-defibrillator lead to avoid inappropriate shock.成功重新定位皮下植入式心律转复除颤器导线以避免不适当电击。
J Arrhythm. 2023 Jan 4;39(1):74-77. doi: 10.1002/joa3.12805. eCollection 2023 Feb.
2
Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.Brugada 综合征患者植入心脏复律除颤器后的结局：一项多中心研究 - 第 2 部分。
Circulation. 2013 Oct 15;128(16):1739-47. doi: 10.1161/CIRCULATIONAHA.113.001941. Epub 2013 Aug 30.
3
Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold.对于皮下植入式心律转复除颤器患者，将电极从左侧重新放置到胸骨右缘对显示高除颤阈值的有效性。
J Arrhythm. 2018 Dec 7;35(1):133-135. doi: 10.1002/joa3.12145. eCollection 2019 Feb.
4
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.药物诱导 1 型 ECG 图形 Brugada 综合征患者中皮下与经静脉植入式心脏复律除颤器的比较：来自 IBRYD 研究的倾向评分匹配分析。
Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24.
5
Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention.Brugada综合征中不适当的植入式心律转复除颤器电击：一级和二级预防模式
Indian Pacing Electrophysiol J. 2017 Jan-Feb;17(1):10-15. doi: 10.1016/j.ipej.2016.10.010. Epub 2016 Oct 24.
6
Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.在 Brugada 综合征病例中，频繁治疗室颤风暴后对皮下植入式心律转复除颤器产生抗药性。
BMC Cardiovasc Disord. 2020 Mar 13;20(1):134. doi: 10.1186/s12872-020-01405-4.
7
Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.完全皮下植入式除颤器对终止Brugada综合征自发性室颤的电击疗效。
Heart Rhythm. 2013 Dec;10(12):1807-9. doi: 10.1016/j.hrthm.2013.08.008. Epub 2013 Aug 8.
8
Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.与高电压阻抗和皮下植入式除颤器心室颤动转复成功相关的因素。
Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e006665. doi: 10.1161/CIRCEP.118.006665.
9
Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome - The first case of associated inappropriate shock in Japan.布加综合征患者皮下植入式心律转复除颤器植入后不久进行运动测试的重要性——日本首例相关不适当电击病例
J Arrhythm. 2017 Apr;33(2):156-158. doi: 10.1016/j.joa.2016.07.006. Epub 2017 Mar 6.
10
Usefulness of lead repositioning to improve subcutaneous electrocardiogram sensing in patients with arrhythmogenic right ventricular cardiomyopathy with subcutaneous implantable cardioverter-defibrillator.在植入皮下植入式心律转复除颤器的致心律失常性右室心肌病患者中，导线重新定位对改善皮下心电图感知的有效性。
HeartRhythm Case Rep. 2020 Aug 4;6(10):786-790. doi: 10.1016/j.hrcr.2020.07.023. eCollection 2020 Oct.

本文引用的文献

1
The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials.皮下植入式心律转复除颤器：对“未触及”和“执政官”试验的综述
Arrhythm Electrophysiol Rev. 2021 Jul;10(2):108-112. doi: 10.15420/aer.2020.47.
2
Incidence, mechanisms, and clinical impact of inappropriate shocks in patients with a subcutaneous defibrillator.皮下植入式除颤器患者中不适当电击的发生率、机制和临床影响。
Europace. 2020 May 1;22(5):761-768. doi: 10.1093/europace/euaa026.
3
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
皮下与经静脉植入式心脏除颤器治疗：病例对照研究的荟萃分析。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
4
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.皮下植入式心律转复除颤器上市后研究：临床特征和围手术期结果。
Heart Rhythm. 2017 Oct;14(10):1456-1463. doi: 10.1016/j.hrthm.2017.05.016. Epub 2017 May 11.
5
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).2015年欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防指南：欧洲心脏病学会（ESC）室性心律失常患者管理和心脏性猝死预防特别工作组。认可机构：欧洲儿科和先天性心脏病协会（AEPC）。
Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29.